A straighter profile does not necessarily mean a smaller nose. With filler, the change comes from adding material. That distinction matters before discussing a photograph, a product or a price.
The other part of the decision is risk. A procedure without an incision can still affect blood vessels, skin and sight. Understanding both the intended change and the possible harm is part of deciding whether to proceed.
01 / 04
The change
What adding material can achieve.
What can filler change?
Filler placed around a hump can make the profile look straighter without removing the hump itself. It can also alter tip projection or soften a small asymmetry. These are changes in contour through addition, rather than reduction of the underlying bone or cartilage. [1]
If your goal is a smaller or narrower nose, that distinction is especially important. The result needs to be considered from the front and at an angle as well as in profile; one flattering view is not the whole outcome.
Previous nose surgery needs particular attention. A technical review advises avoiding filler where the soft tissue over the nose is markedly tight after surgery. An examination and the details of previous procedures therefore matter. [1]
What about breathing?
Some specialist techniques use filler to support a collapsing nasal valve. Their description in a review does not establish how well they work for everyone with nasal obstruction. A blocked nose needs a diagnosis before a cosmetic treatment is considered as a solution. [1]
02 / 04
The evidence
Satisfaction is useful, but it has limits.
How satisfied were patients?
A review of eight studies involving 674 patients reported that 333 of the 393 assessed at three months were satisfied or very satisfied: 84.7%. These were pooled reports from different studies, with different numbers assessed at different times. They do not describe one group steadily improving or declining. [2]
Satisfaction tells us something valuable about how people felt. It does not by itself establish how the procedure compares with surgery or no treatment, how every appearance was assessed, or what happened to patients who were not followed up.
How long might the result last?
The same review reported effects lasting eight to fourteen months. Treat that as a range reported in those studies, not an expiry date for your result or a guarantee that all filler has disappeared by then. [2] The material and the site influence duration. [7]
Longer-lasting changes in the nose have also been reported; the eight-to-fourteen-month range is not an upper limit. [1]
Before any further treatment, the starting point should be the nose as it is now: the remaining change, any problems and the result you still want. A calendar alone does not show that more volume is needed.
03 / 04
The risk
A small reported percentage can describe a serious outcome.
What can go wrong?
Swelling, bruising and redness can occur after filler; many early effects resolve over days to weeks. Infection and lumps are also recognised complications. [7]
If filler blocks a vessel, tissue can lose its blood supply. In the nose, vessels communicate with the circulation supplying the eye. Filler can reach that circulation and cause sight loss; skin damage and stroke have also been reported. [1][7]
Can research give a reliable personal risk?
One systematic review included 37 publications: 23 cohort studies and 14 case reports, covering 8,604 patients. It reported eight instances of vision loss (0.09%), seven of skin necrosis (0.08%) and 30 episodes of vessel occlusion (0.35%). The review separately estimated an overall adverse-outcome rate of 2.52% across its cohort studies; that pooled estimate is not the combined rate of the specific complications listed here. [3]
Those figures describe the literature assembled by the review. The mixture of cohorts and case reports, differences in reporting and possible missing complications mean that 0.09% should not be presented as a precise personal probability. A separate critical review highlighted the lack of high-quality evidence and possible underreporting. [3][4]
A different review collected 48 published cases of filler-related vision loss from 2015–2018. The nose was involved in 56.3%. That is the share of reported vision-loss cases involving the nose, not the percentage of people having nose filler who lost vision. [5]
Does “dissolvable” mean reversible?
Hyaluronic acid can be broken down with hyaluronidase. That does not guarantee reversal of damage already caused by a blocked vessel, and the enzyme is not a general antidote for every filler material. [6][7]
In the review of 48 vision-loss cases, ten people recovered vision completely and eight partly; the authors found no consistently successful treatment. Those reported recoveries cannot establish the chance of recovery for a new patient. [5]
UK consensus guidance published in 2026 sets out urgent specialist-care pathways. It does not establish a reliably successful rescue. A clinician needs a plan for complications before treatment begins, including access to emergency equipment and care. [6]
04 / 04
The decision
A clear plan before any injection.
What happens at the appointment?
Before treatment, the practitioner should explain the proposed change, risks, cost and aftercare, and give you time to decide. Ask how long your particular procedure is expected to take and how discomfort will be managed. [8]
Numbing cream may be used before nose filler, although it is not always needed. Photographs and consent form part of the preparation described in the technical review. [1]
What should I expect on the first day?
Tenderness, swelling, redness or bruising may appear shortly after injection. Many early effects settle over days to weeks; the appearance on the day is therefore not necessarily the settled result. [7]
Leave with written aftercare and a contact route for concerns. Ask specifically about work, exercise, glasses and any upcoming event. The plan should suit your treatment rather than promise that everyone can return immediately to everything. [8]
Increasing or unusual pain, a change in skin colour or any visual symptom belongs in the urgent-help guidance below, rather than being dismissed as ordinary recovery.
Which questions are worth asking?
What change is realistic for my nose, and what would remain unchanged? Which material would be used? What previous filler or surgery needs to be considered? What are the alternatives, including doing nothing?
Ask about the clinician’s training and experience with the nose, how complications are recognised and managed, and who can be contacted afterwards. For a hyaluronic-acid filler, ask whether hyaluronidase is available and whether the clinician is trained to use it. A confident answer about dissolving filler should still acknowledge the limits of treating sight-threatening complications. [6]
Which symptoms need urgent help?
A sudden change in vision or symptoms suggesting a stroke need emergency medical attention. Tell the treating clinician immediately if they are present, and seek emergency care without delay. Do not drive yourself if your vision is affected. [6][7]
Unusual or severe pain, or skin near the injection site becoming white, grey or blue, also needs immediate medical assessment. Do not wait for a routine follow-up appointment to report it. [7]
What should the decision rest on?
The useful question is not whether a result can look impressive in a photograph. It is whether the achievable change addresses your concern well enough to justify the risks for you.
An assessment should leave you able to describe the proposed change, the important limitations and the plan if something goes wrong. Taking time to decide, choosing another approach or leaving your nose as it is are all legitimate outcomes.
References
[1] Hall and Kontis. Nonsurgical rhinoplasty. 2023. Read source ↗
[2] Radulesco et al. Patient Satisfaction After Non-surgical Rhinoplasty Using Hyaluronic Acid. 2021. Read source ↗
[3] DeVictor, Ong and Sherris. Complications Secondary to Nonsurgical Rhinoplasty: A Systematic Review and Meta-analysis. 2021. Read source ↗
[4] Babu and Rapaport. A critical review of complications in non-surgical rhinoplasty and their management. 2021. Read source ↗
[5] Beleznay et al. Update on Avoiding and Treating Blindness From Fillers. 2019. Read source ↗
[6] Sansome et al. UK consensus guidelines for tissue filler-induced vision loss. 2026. Read source ↗
[7] US Food and Drug Administration. Dermal fillers (soft tissue fillers). Read source ↗
[8] NHS. Choosing who will do your cosmetic procedure. Consultation and aftercare questions; accessed 16 October 2026. Read source ↗
Sources checked 16 October 2026. This is a focused evidence review. Several research reports were available at abstract level; the source ledger records access and limits. Published complication figures are not a precise prediction of individual risk.